GLOSTRUP, Denmark – First Complementary Diagnostic Approved to Support Use of Bristol-Myers Squibb’s OPDIVO for Non-Squamous Non-Small Cell Lung Cancer Dako, an Agilent Technologies company and a worldwide provider of cancer diagnostics, announced Oct. 9 that the U.S. Food and Drug Administration has approved a new test that can identify PD-L1 expression levels on the […]
bioMérieux (Paris:BIM), a world leader in the field of in vitro diagnostics, today announced, as issued in a press release by the U.S. Food and Drug Administration (FDA) yesterday, that BioFire Diagnostics, its molecular biology affiliate, has received a de novo clearance from the FDA for the FilmArray® Meningitis/Encephalitis (ME) Panel. With its unique and […]
ST. LOUIS — Sigma-Aldrich Corporation (NASDAQ: SIAL) announced today that the Cerilliant® brand within its Applied Diagnostics and Testing business segment has launched its new bile acid reference standards product line with ten certified Snap-N-Spike® solutions of the most routinely tested bile acids and their stable-labeled internal standards. These new solution certified reference materials (CRMs) […]
SANTA CLARA, Calif. – Agilent Technologies Inc. (NYSE: A) is sharing its vision for precision medicine this week at the annual meeting of the American Society of Human Genomics. The conference, held in Baltimore, Maryland, is a forum for discussing recent advances in all areas of human genetics. “As new technologies and greater understanding of […]
Cambridge, UK: Horizon Discovery Group plc (LSE: HZD) (“Horizon” or “the Company”), the international life science company supplying research tools and services that power genomics research and the development of personalised medicines, announces today that its leveraged business unit has signed a programme in-licensing and option agreement with Servier, the independent French research-based pharmaceutical company […]
AUSTIN, Texas — Luminex Corporation (NASDAQ: LMNX) today announced that it has received FDA clearance for the company’s ARIES® System and ARIES® HSV 1&2 Assay. ARIES® is a sample to answer system designed to increase laboratory efficiency, ensure result accuracy, and fit seamlessly into today’s lean laboratory environment. ARIES® uses internal barcode scanning and other […]
New Affymetrix HLA Analysis Software Quickly Delivers High-Resolution HLA Types from Genotyping Data
SANTA CLARA, Calif. –Affymetrix (NASDAQ: AFFX) introduces Axiom™ HLA Analysis software for automated, high-resolution human leukocyte antigen (HLA) typing from any genotyping dataset containing coverage of the extended major histocompatibility complex (MHC) region. The software’s unique imputation algorithm enables 4-digit HLA typing from genome-wide association studies (GWAS), combining genotyping and high-resolution HLA typing into a […]
Oxford, UK – Oxford Gene Technology (OGT), The Molecular Genetics Company, has launched its CE-IVD labelled Cytocell Aquarius® P16/3c/7c/17c Probe Kit, a cost-effective, ready-to-use fluorescence in situ hybridisation (FISH) probe kit for non-invasive detection of bladder cancer — for sale in Europe. Bladder cancer is becoming increasingly prevalent, and in 2012 was reported as the […]
Santa Clara, CA – Affymetrix, Inc. (NASDAQ: AFFX) announced today that its Axiom® high-throughput genotyping technology was instrumental in two transplantation peer-reviewed publications issued this month by an international team of surgeons and scientists. The consortium – International Genetics and Translational Research in Transplantation Network (iGeneTRAiN) – co-led by researchers from the Perelman School of […]
BC Platforms, a world leader in genomic data management solutions, today announced that theUniversity of Colorado Anschutz Medical Campus will use the company’s world-leading, comprehensive data management program to support the launch of the university’s new personalized medicine initiative aiming at translating community genomics into individual well-being. A major goal of the program is to […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
